US-based therapeutics device company Clarimedix secured an undisclosed amount of funding on Wednesday from the Johnson & Johnson Corporate Office of Science and Technology (COSAT), part of the pharmaceutical conglomerate’s website where innovators submit ideas to Johnson & Johnson operating companies..

Clarimedix focuses its research on disorders associated with blood vessel problems, Alzheimer’s disease among them. The technology used by Clarimedix involves a ligh-emitting diode (LED) patch that can be placed on the skin to trigger nitric oxide production in…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?